Eping, Adzmar .
HRN: 26-35-48 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/12/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
12/12/2024
12/19/2024
IV
700mg
Q6hours
PCAP-C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes